KeyZell start-up plans to reach 5 million euros in private investment and become the new biotech unicorn
KeyZell, a Spanish biotechnology company in the development phase of digital cancer treatments and tools, has just opened a private financing round which expects to achieve 5 million euros to boost its projects and consolidate itself as one of the biotech start-ups with the greatest international projection. KeyZell launches this new round of private investment […]
